ID   AREG_RAT                Reviewed;         243 AA.
AC   P24338;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-1992, sequence version 1.
DT   29-MAY-2024, entry version 144.
DE   RecName: Full=Amphiregulin;
DE            Short=AR;
DE   AltName: Full=Schwannoma-derived growth factor;
DE            Short=SDGF;
DE   Flags: Precursor;
GN   Name=Areg; Synonyms=Sdgf;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=2234093; DOI=10.1038/348257a0;
RA   Kimura H., Fischer W.H., Schubert D.;
RT   "Structure, expression and function of a schwannoma-derived growth
RT   factor.";
RL   Nature 348:257-260(1990).
CC   -!- FUNCTION: Ligand of the EGF receptor/EGFR. Autocrine growth factor as
CC       well as a mitogen for a broad range of target cells including
CC       astrocytes, Schwann cells and fibroblasts.
CC   -!- SUBUNIT: The immature precursor interacts with CNIH. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the amphiregulin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X55183; CAA38967.1; -; mRNA.
DR   PIR; S13296; S13296.
DR   RefSeq; NP_058819.1; NM_017123.1.
DR   AlphaFoldDB; P24338; -.
DR   SMR; P24338; -.
DR   STRING; 10116.ENSRNOP00000003703; -.
DR   GlyCosmos; P24338; 3 sites, No reported glycans.
DR   GlyGen; P24338; 3 sites.
DR   PhosphoSitePlus; P24338; -.
DR   PaxDb; 10116-ENSRNOP00000003703; -.
DR   Ensembl; ENSRNOT00000003703.5; ENSRNOP00000003703.2; ENSRNOG00000002754.5.
DR   Ensembl; ENSRNOT00055010381; ENSRNOP00055008057; ENSRNOG00055006387.
DR   Ensembl; ENSRNOT00060029802; ENSRNOP00060024016; ENSRNOG00060017437.
DR   Ensembl; ENSRNOT00065031384; ENSRNOP00065025011; ENSRNOG00065018693.
DR   GeneID; 29183; -.
DR   KEGG; rno:29183; -.
DR   UCSC; RGD:2149; rat.
DR   AGR; RGD:2149; -.
DR   CTD; 374; -.
DR   RGD; 2149; Areg.
DR   eggNOG; ENOG502S0KA; Eukaryota.
DR   GeneTree; ENSGT00940000160696; -.
DR   HOGENOM; CLU_096527_1_0_1; -.
DR   InParanoid; P24338; -.
DR   OMA; CHHDYFG; -.
DR   OrthoDB; 4334035at2759; -.
DR   PhylomeDB; P24338; -.
DR   TreeFam; TF332773; -.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-177929; Signaling by EGFR.
DR   Reactome; R-RNO-179812; GRB2 events in EGFR signaling.
DR   Reactome; R-RNO-180292; GAB1 signalosome.
DR   Reactome; R-RNO-180336; SHC1 events in EGFR signaling.
DR   Reactome; R-RNO-182971; EGFR downregulation.
DR   Reactome; R-RNO-204005; COPII-mediated vesicle transport.
DR   Reactome; R-RNO-212718; EGFR interacts with phospholipase C-gamma.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-5694530; Cargo concentration in the ER.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-RNO-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-RNO-9009391; Extra-nuclear estrogen signaling.
DR   PRO; PR:P24338; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000002754; Expressed in duodenum and 10 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; IDA:RGD.
DR   GO; GO:0008083; F:growth factor activity; IDA:RGD.
DR   GO; GO:0048018; F:receptor ligand activity; ISO:RGD.
DR   GO; GO:0030297; F:transmembrane receptor protein tyrosine kinase activator activity; ISO:RGD.
DR   GO; GO:0060598; P:dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis; ISO:RGD.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; IDA:RGD.
DR   GO; GO:0060750; P:epithelial cell proliferation involved in mammary gland duct elongation; ISO:RGD.
DR   GO; GO:0038134; P:ERBB2-EGFR signaling pathway; ISO:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0014009; P:glial cell proliferation; IDA:RGD.
DR   GO; GO:0060749; P:mammary gland alveolus development; ISO:RGD.
DR   GO; GO:0060744; P:mammary gland branching involved in thelarche; ISO:RGD.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; IDA:RGD.
DR   GO; GO:0031175; P:neuron projection development; IMP:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; IDA:RGD.
DR   GO; GO:0051591; P:response to cAMP; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; ISO:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IMP:RGD.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   Gene3D; 2.10.25.10; Laminin; 1.
DR   InterPro; IPR000742; EGF-like_dom.
DR   PANTHER; PTHR10740:SF12; AMPHIREGULIN; 1.
DR   PANTHER; PTHR10740; TRANSFORMING GROWTH FACTOR ALPHA; 1.
DR   SUPFAM; SSF57196; EGF/Laminin; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
PE   1: Evidence at protein level;
KW   Cytokine; Direct protein sequencing; Disulfide bond; EGF-like domain;
KW   Glycoprotein; Growth factor; Membrane; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   PROPEP          25..96
FT                   /id="PRO_0000007478"
FT   CHAIN           97..243
FT                   /note="Amphiregulin"
FT                   /id="PRO_0000007479"
FT   TRANSMEM        190..213
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          133..173
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REGION          55..75
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          98..135
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        55..69
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        98..114
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        115..135
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        30
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        103
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        236
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        137..150
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        145..161
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        163..172
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   243 AA;  26633 MW;  F59A8173D4921599 CRC64;
     MRTPSLSLAL SVLSLLVLGS GHYAAGLELN GTSSGKGEPS SGDHSAGGLV VSEVSTISEM
     PSGSELSTGD YDYSEEYDNE PQISGYIVDD SVRVEQVIKP KENKTEGEKS SEKPKRKKKG
     GKGGKGRRNR KKKKNPCAAK FQNFCIHGEC RYIENLEVVT CHCHQDYFGE RCGEKTMKTQ
     KKDDSDLSKI ALAAIIVFVS AVSVAAIGII TAVLLRKRFF REYEEAEERR RLRQENGTAH
     AIA
//
